- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/08 - Bridged systems
Patent holdings for IPC class C07D 487/08
Total number of patents in this class: 1954
10-year publication summary
|
91
|
96
|
101
|
105
|
112
|
112
|
148
|
168
|
173
|
137
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4855 |
95 |
| Boehringer Ingelheim International GmbH | 4646 |
37 |
| Merck Sharp & Dohme LLC | 3757 |
37 |
| Janssen Pharmaceutica N.V. | 3362 |
35 |
| Gilead Sciences, Inc. | 2049 |
33 |
| Novartis AG | 10725 |
27 |
| F. Hoffmann-La Roche AG | 7947 |
25 |
| Genentech, Inc. | 4001 |
25 |
| Pfizer Inc. | 3375 |
23 |
| Vertex Pharmaceuticals Incorporated | 1627 |
23 |
| Astellas Pharma Inc. | 1085 |
23 |
| Hoffmann-La Roche Inc. | 3468 |
21 |
| Rigel Pharmaceuticals, Inc. | 538 |
18 |
| Incyte Corporation | 1024 |
16 |
| Sanofi | 4093 |
15 |
| Biosplice Therapeutics, Inc. | 171 |
15 |
| Astex Therapeutics Limited | 242 |
13 |
| Clarity Pharmaceuticals Limited | 48 |
13 |
| Amgen Inc. | 4105 |
12 |
| Arvinas Operations, Inc. | 234 |
12 |
| Other owners | 1436 |